Healthcare experiences of People with Parkinson’s Disease (PwP) during COVID-19 pandemic
Objective: To investigate how our group of PwP coped with healthcare issues during the pandemic. Background: COVID-19 pandemic led to changes in how healthcare services…Dynamic assessment of levels of depression and anxiety impairment in Parkinson’s disease
Objective: To dynamic assessment of depression and anxiety disorders in Parkinson's disease. Background: One of the most common nonmotor disturbances in Parkinson's disease (PD) is…Recruitment of Parkinson’s disease patients with mild-to-moderate anxiety into a randomized controlled trial: Experience of a large Canadian tertiary movement disorders clinic
Objective: To report our experience of recruiting Parkinson’s disease (PD) patients with mild-to-moderate anxiety into a randomized controlled trial. Background: Anxiety is a common non-motor…Longitudinal assessment of evolution and plasma biomarkers for depression and anxiety in Parkinson’s disease
Objective: We aimed to investigatethe evolution of depression and anxietyin a large Parkinson's disease (PD) cohort and explore the related plasma biomarkers. Background: Depression and anxietyare common non-motor…Association between type 2 diabetes mellitus with parkinson’s disease and the increase of the severity of depression and anxiety in a mexican population
Objective: To compare the severity of depression and anxiety in PwP between those with T2D and those without T2D. Background: Parkinson's disease (PD) is the…A Randomized, Wait-List Controlled Trial of the Feasibility and Efficacy of Small Group Online-based Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease
Objective: To investigate the feasibility and efficacy of online-based Cognitive Behavioral Therapy (CBT) for anxiety in Parkinson's disease (PD). Background: Anxiety symptoms in Parkinson's disease…Predictors of short-term anxiety outcome after subthalamic stimulation in Parkinson’s Disease
Objective: To identify clinical predictors of the effect of subthalamic nucleus deep brain stimulation (STN-DBS) on anxiety in Parkinson’s Disease (PD). Background: STN-DBS is a…Validation of the English version of the Parkinson Anxiety Scale in the Canadian population: Interim results
Objective: To validate the use of the English version of the PAS in Parkinson’s disease (PD) patients in Canada. Background: The PAS, originally developed to…Cognitive behavioral therapy for anxiety in Parkinson’s disease induces functional brain changes
Objective: To identify changes in functional connectivity in the brain after cognitive behavioral therapy (CBT) for anxiety in patients with Parkinson's disease (PD). Background: CBT…The influence of GBA and LRRK2 on mood disorders in Parkinson’s Disease
Objective: To assess the influence of mutations in the LRRK2 and GBA genes on mood disorders among patients with Parkinson's disease (PD) Background: Mood disorders…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 19
- Next Page »